This page is part of the electronic Case Reporting (eCR) (v2.0.0: STU 2 on FHIR R4) based on FHIR R4. The current version which supercedes this version is 2.1.0. For a full list of available versions, see the Directory of published versions
{
"resourceType" : "ValueSet",
"id" : "valueset-mrtc-example",
"meta" : {
"versionId" : "6",
"lastUpdated" : "2020-12-03T05:57:10.741+00:00",
"source" : "#jZvYkGxPTEYqKf6v",
"profile" : [
"http://hl7.org/fhir/us/ecr/StructureDefinition/us-ph-triggering-valueset"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><ul><li>Include these codes as defined in <a href=\"http://www.nlm.nih.gov/research/umls/rxnorm\"><code>http://www.nlm.nih.gov/research/umls/rxnorm</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>809002</td><td>Carbidopa 10 MG / Levodopa 100 MG Disintegrating Oral Tablet [Parcopa]</td></tr><tr><td>476515</td><td>Carbidopa 25 MG / Levodopa 250 MG Disintegrating Oral Tablet</td></tr><tr><td>308988</td><td>Carbidopa 25 MG / Levodopa 100 MG Extended Release Oral Tablet</td></tr><tr><td>724606</td><td>Carbidopa 10 MG / Levodopa 100 MG Oral Tablet [Sinemet]</td></tr><tr><td>1600914</td><td>8 HR Carbidopa 48.75 MG / Levodopa 195 MG Extended Release Oral Capsule</td></tr><tr><td>476399</td><td>Carbidopa 25 MG / Levodopa 100 MG Disintegrating Oral Tablet</td></tr></table></li></ul></div>"
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-steward",
"valueContactDetail" : {
"name" : "CSTE Steward"
}
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail" : {
"name" : "CSTE Author"
}
}
],
"url" : "http://hl7.org/fhir/us/ecr/ValueSet/valueset-mrtc-example",
"identifier" : [
{
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113762.1.4.1146.1060"
}
],
"version" : "2.0.0",
"name" : "Example_Medications_Triggers_for_Public_Health_Reporting",
"title" : "Example Medications Triggers for Public Health Reporting",
"status" : "active",
"experimental" : true,
"date" : "2018-08-01",
"publisher" : "HL7 Public Health Work Group (http://www.hl7.org/Special/committees/pher/index.cfm)",
"contact" : [
{
"name" : "HL7 International - Public Health",
"telecom" : [
{
"system" : "url",
"value" : "http://www.hl7.org/Special/committees/pher"
}
]
}
],
"description" : "This example set of values contains CVX, RXNORM,and SNOMED medication codes that may represent that the patient may have a potentially reportable condition. These pertain to medications administered and medications prescribed, where the medication, coded in CVX,RXNORM,SNOMED, may be indicative of a reportable condition.",
"useContext" : [
{
"code" : {
"system" : "http://hl7.org/fhir/us/ecr/CodeSystem/us-ph-usage-context-type",
"code" : "reporting",
"display" : "Reporting"
},
"valueCodeableConcept" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/us/ecr/CodeSystem/us-ph-usage-context",
"code" : "triggering",
"display" : "Triggering"
}
]
}
}
],
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "US",
"display" : "United States of America"
}
],
"text" : "United States of America"
}
],
"purpose" : "Prescription drugs names used in observations documented in a clinical record.",
"compose" : {
"include" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"concept" : [
{
"code" : "809002",
"display" : "Carbidopa 10 MG / Levodopa 100 MG Disintegrating Oral Tablet [Parcopa]"
},
{
"code" : "476515",
"display" : "Carbidopa 25 MG / Levodopa 250 MG Disintegrating Oral Tablet"
},
{
"code" : "308988",
"display" : "Carbidopa 25 MG / Levodopa 100 MG Extended Release Oral Tablet"
},
{
"code" : "724606",
"display" : "Carbidopa 10 MG / Levodopa 100 MG Oral Tablet [Sinemet]"
},
{
"code" : "1600914",
"display" : "8 HR Carbidopa 48.75 MG / Levodopa 195 MG Extended Release Oral Capsule"
},
{
"code" : "476399",
"display" : "Carbidopa 25 MG / Levodopa 100 MG Disintegrating Oral Tablet"
}
]
}
]
}
}